MHRA's strategic principles aim to foster innovation while upholding rigorous standards of patient safety and regulatory integrity
In a recent announcement the Medicines and Healthcare...
People are warned that use of unbranded devices could exacerbate the situation by pushing obstructions further down into the airway passageÂ
The Medicines and Healthcare...
Studies showed that 26% of those who received the once-daily tablet achieved clinical remission after 12 weeks of treatment. Â Â
American pharmaceutical giant Pfizer has...
XGEVA is the first product to be authorised by the regulator through the new International Recognition Procedure (IRP).
The latest formulation of XGEVA (denosumab)...